• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2100008 重组人血管内皮抑制素注射液 Recombinant Human Endostatin Injection Biological Products(2.2) New Drug Application 2021-01-09 山东先声生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd In Review 2021-01-08 view
CYSB2000017 重组人血管内皮抑制素注射液 Recombinant Human Endostatin Injection Biological Products Supplementary Application 2020-01-23 山东先声生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd In Review 2020-01-22 view
CXSL1100045 注射用聚乙二醇化重组人血管内皮抑制素 Lyophilized Biological Products(9) New Drug Application 2011-12-01 山东先声麦得津生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd Certificate Issued 2014-07-31 view
CYSB1100375 重组人血管内皮抑制素注射液 Recombinant Human Endostatin Injection Biological Products Supplementary Application 2011-07-27 山东先声麦得津生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd Certificate Issued 2013-05-31 view
CXSB1000001 重组人血管内皮抑制素注射液 Recombinant Human Endostatin Injection Biological Products Supplementary Application 2010-04-12 山东先声麦得津生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd In Review 2012-07-02 view
CXSB0700080 重组人血管内皮抑制素注射液 Recombinant Human Endostatin Injection Biological Products Supplementary Application 2007-08-27 山东先声麦得津生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd Certificate Issued 2008-09-19 view
CXSB0600125 重组人血管内皮抑制素注射液 Recombinant Human Endostatin Injection Biological Products Supplementary Application 2006-12-14 山东先声麦得津生物制药有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd Certificate Issued 2007-09-18 view
X0405545 重组人血管内皮抑制素 Recombinant Human Endostatin Injection Biological Products New Drug Application 2004-09-30 烟台麦得津生物工程股份有限公司 Shandong Simcere Bio-Pharmaceutical Co Ltd Certificate Issued 2005-09-22 view